Please try another search
Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Name | Age | Since | Title |
---|---|---|---|
Laura A. Brege | 66 | 2011 | Independent Director |
Mark A. Kronenfeld | 69 | 2013 | Independent Director |
Frank D. Lee | 56 | 2024 | CEO & Director |
Paul J. Hastings | 64 | 2011 | Chairman of the Board |
Gary W. Pace | 76 | 2008 | Independent Director |
Mark I. Froimson | 63 | 2017 | Independent Director |
Michael J. Yang | 62 | 2023 | Independent Director |
Abraham N. Ceesay | 46 | 2023 | Independent Director |
Andreas Wicki | 66 | 2006 | Independent Director |
Christopher J. Christie | 61 | 2019 | Independent Director |
Alethia Rene Young | 45 | 2023 | Independent Director |
Marcelo Bigal | - | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review